Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inspire Medical Systems Inc (NY: INSP )

177.17 +1.27 (+0.72%)
Official Closing Price Updated: 4:10 PM EDT, May 23, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 166,541
Open 177.70
Bid (Size) 141.23 (1)
Ask (Size) 265.00 (1)
Prev. Close 175.90
Today's Range 173.22 - 179.97
52wk Range 142.74 - 286.29
Shares Outstanding 27,271,598
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Inspire Medical Systems: Q1 Earnings Insights
Inspire Medical Systems (NYSE:INSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Inspire Medical Systems's Earnings Outlook
Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga

Performance

YTD
-25.55%
-25.55%
1 Month
-20.86%
-20.86%
3 Month
-19.49%
-19.49%
6 Month
-30.72%
-30.72%
1 Year
-2.59%
-2.59%

More News

Read More
Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Via Benzinga
Executive Chairman Bill Ford Continues To Buy More Ford Shares
Via Benzinga
Executives Sell Over $640M Of 5 Stocks
Via Benzinga
Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus
Via Benzinga
Inspire Medical Systems: Q4 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Via Benzinga
Earnings Scheduled For February 8, 2022
Via Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Via Benzinga
Inspire Medical Expects Strong Q4 FY21 Revenue Growth
Via Benzinga
A Peek Into The Markets: US Stock Futures Mixed After Dow Records Another High
Via Benzinga
5 Stocks To Watch For January 5, 2022
Via Benzinga
Atrial Fibrillation Market Is Expected To Reach  $11.123 Billion At A CAGR 11.2 % Through 2023
Via FinancialNewsMedia
Topics Death
Exposures Death
Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Via Benzinga
Exposures COVID-19
Analyst Ratings For Inspire Medical Systems
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Via Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Via Benzinga
Exposures COVID-19
Looking into Inspire Medical Systems's Return on Capital Employed
Via Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.